MALAT1 and glioma: Furthermore, MALAT1 promotes glioma cell proliferation and TMZ resistance by decreasing miR-203 expression and increasing the expression of thymidylate synthase (TS), a potent cancer chemotherapy target (Chu et al. 2003; Chen et al. 2017).